Relative Bioavailability of BI 671800 HEA in Healthy Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the relative bioavailability of single doses of 200 mg BI 671800 HEA (choline)
administered as a delayed release (enteric coated) tablet; or via the EnterionTM capsule as
solution to the jejunum, ascending or descending colon, or as particulate to the ascending
colon